1.Guidelines for the Surgical Management of Oral Cancer: Korean Society of Thyroid-Head and Neck Surgery
Young hoon JOO ; Jae keun CHO ; Bon seok KOO ; Minsu KWON ; Seong keun KWON ; Soon young KWON ; Min su KIM ; Jeong kyu KIM ; Heejin KIM ; Innchul NAM ; Jong lyel ROH ; Young min PARK ; Il seok PARK ; Jung je PARK ; Sung chan SHIN ; Soon hyun AHN ; Seongjun WON ; Chang hwan RYU ; Tae mi YOON ; Giljoon LEE ; Doh young LEE ; Myung chul LEE ; Joon kyoo LEE ; Jin choon LEE ; Jae yol LIM ; Jae won CHANG ; Jeon yeob JANG ; Man ki CHUNG ; Yuh seok JUNG ; Jae gu CHO ; Yoon seok CHOI ; Jeong seok CHOI ; Guk haeng LEE ; Phil sang CHUNG
Clinical and Experimental Otorhinolaryngology 2019;12(2):107-144
Korean Society of Thyroid-Head and Neck Surgery appointed a Task Force to provide guidance on the implementation of a surgical treatment of oral cancer. MEDLINE databases were searched for articles on subjects related to “surgical management of oral cancer” published in English. Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies. The quality of evidence was rated with use RoBANS (Risk of Bias Assessment Tool for Nonrandomized Studies) and AMSTAR (A Measurement Tool to Assess the Methodological Quality of Systematic Reviews). Evidence-based recommendations for practice were ranked according to the American College of Physicians grading system. Additional directives are provided as expert opinions and Delphi questionnaire when insufficient evidence existed. The Committee developed 68 evidence-based recommendations in 34 categories intended to assist clinicians and patients and counselors, and health policy-makers. Proper surgical treatment selection for oral cancer, which is directed by patient- and subsite-specific factors, remains the greatest predictor of successful treatment outcomes. These guidelines are intended for use in conjunction with the individual patient's treatment goals.
Advisory Committees
;
Bias (Epidemiology)
;
Carcinoma, Squamous Cell
;
Counseling
;
Expert Testimony
;
Humans
;
Mouth Neoplasms
;
Neck
;
Republic of Korea
2.Association between Serum Selenium Level and the Presence of Diabetes Mellitus: A Meta-Analysis of Observational Studies
Juno KIM ; Hye Soo CHUNG ; Min Kyu CHOI ; Yong Kyun ROH ; Hyung Joon YOO ; Jung Hwan PARK ; Dong Sun KIM ; Jae Myung YU ; Shinje MOON
Diabetes & Metabolism Journal 2019;43(4):447-460
BACKGROUND: Epidemiological studies have suggested an association between selenium (Se) and diabetes mellitus (DM). However, different studies have reported conflicting results. Therefore, we performed a comprehensive meta-analysis to clarify the impact of Se on DM. METHODS: We searched the PubMed database for studies on the association between Se and DM from inception to June 2018. RESULTS: Twenty articles evaluating 47,930 participants were included in the analysis. The meta-analysis found that high levels of Se were significantly associated with the presence of DM (pooled odds ratios [ORs], 1.88; 95% confidence interval [CI], 1.44 to 2.45). However, significant heterogeneity was found (I2 =82%). Subgroup analyses were performed based on the Se measurement methods used in each study. A significant association was found between high Se levels and the presence of DM in the studies that used blood (OR, 2.17; 95% CI, 1.60 to 2.93; I2 =77%), diet (OR, 1.61; 95% CI, 1.10 to 2.36; I2 =0%), and urine (OR, 1.49; 95% CI, 1.02 to 2.17; I2 =0%) as samples to estimate Se levels, but not in studies on nails (OR, 1.24; 95% CI, 0.52 to 2.98; I2 =91%). Because of significant heterogeneity in the studies with blood, we conducted a sensitivity analysis and tested the publication bias. The results were consistent after adjustment based on the sensitivity analysis as well as the trim and fill analysis for publication bias. CONCLUSION: This meta-analysis demonstrates that high levels of Se are associated with the presence of DM. Further prospective and randomized controlled trials are warranted to elucidate the link better.
Antioxidants
;
Diabetes Mellitus
;
Diet
;
Epidemiologic Studies
;
Odds Ratio
;
Population Characteristics
;
Prospective Studies
;
Publication Bias
;
Selenium
;
Trace Elements
3.Comparison of Squamous Cell Carcinoma of the Tongue between Young and Old Patients
Gyuheon CHOI ; Joon Seon SONG ; Seung Ho CHOI ; Soon Yuhl NAM ; Sang Yoon KIM ; Jong Lyel ROH ; Bu Kyu LEE ; Kyung Ja CHO
Journal of Pathology and Translational Medicine 2019;53(6):369-377
BACKGROUND: The worldwide incidence of squamous cell carcinoma of the tongue (SCCOT) in young patients has been increasing. We investigated clinicopathologic features of this unique population and compared them with those of SCCOT in the elderly to delineate its pathogenesis.METHODS: We compared clinicopathological parameters between patients under and over 45 years old. Immunohistochemical assays of estrogen receptor, progesterone receptor, androgen receptor, p53, p16, mdm2, cyclin D1, and glutathione S-transferase P1 were also compared between them.RESULTS: Among 189 cases, 51 patients (27.0%) were under 45 years of age. A higher proportion of women was seen in the young group, but was not statistically significant. Smoking and drinking behaviors between age groups were similar. Histopathological and immunohistochemical analysis showed no significant difference by age and sex other than higher histologic grades observed in young patients.CONCLUSIONS: SCCOT in young adults has similar clinicopathological features to that in the elderly, suggesting that both progress via similar pathogenetic pathways.
Aged
;
Carcinoma, Squamous Cell
;
Cyclin D1
;
Drinking
;
Drinking Behavior
;
Epithelial Cells
;
Estrogens
;
Female
;
Glutathione Transferase
;
Humans
;
Immunohistochemistry
;
Incidence
;
Mouth Neoplasms
;
Receptors, Androgen
;
Receptors, Progesterone
;
Smoke
;
Smoking
;
Tongue
;
Young Adult
4.The Relationship between Hyperuricemia and Triglyceride Glucose Index: Based on 2016 Korean National Health and Nutrition Examination Survey
Joon Suk BYUN ; Ju No KIM ; Yu Shin SONG ; Yong Kyun ROH ; Min Kyu CHOI
Korean Journal of Family Practice 2019;9(3):266-271
BACKGROUND: Hyperuricemia refers to an excess of uric acid in the blood and is associated with gouty arthritis, hypertension, metabolic syndrome, atrial fibrillation, kidney stones, insulin resistance (IR), and type 2 diabetes mellitus. Previous studies have used the homeostatic model assessment of IR (HOMA-IR), a well-known index of IR, to investigation the correlation between serum uric acid levels and IR. However, difficulty with measuring insulin levels limits the clinical applicability of the HOMA-IR index. This study investigated the correlation between hyperuricemia and the triglyceride glucose (TyG) index.METHODS: We used data from the Seventh Korea National Health and Nutrition Examination Survey, 2016. The study population included adults without diabetes aged >19 years. The TyG index, which serves as an indicator of IR, was calculated using fasting serum glucose and triglyceride levels to investigate the correlation between the TyG index and hyperuricemia. Pearson's correlation coefficient and analysis of covariance were used for statistical analysis, which was performed using IBM SPSS software.RESULTS: A statistically significant correlation was observed between serum uric acid levels and the TyG index. After adjustment for factors that may affect IR (age, body mass index, waist circumference, and systolic and diastolic blood pressures), we observed that the TyG index was significantly higher in the hyperuricemia than in the non-hyperuricemia group (8.96 vs. 8.54, P < 0.001).CONCLUSION: Serum uric acid levels were significantly correlated with IR assessed using the TyG index in adults without diabetes aged >19 years.
Adult
;
Arthritis, Gouty
;
Atrial Fibrillation
;
Blood Glucose
;
Body Mass Index
;
Diabetes Mellitus, Type 2
;
Fasting
;
Glucose
;
Humans
;
Hypertension
;
Hyperuricemia
;
Insulin
;
Insulin Resistance
;
Kidney Calculi
;
Korea
;
Nutrition Surveys
;
Triglycerides
;
Uric Acid
;
Waist Circumference
5.Corrigendum: Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro).
Jae Hoon MOON ; Ji Hoon KIM ; Eun Kyung LEE ; Kyu Eun LEE ; Sung Hye KONG ; Yeo Koon KIM ; Woo Jin JEONG ; Chang Yoon LEE ; Roh Eul YOO ; Yul HWANGBO ; Young Shin SONG ; Min Joo KIM ; Sun Wook CHO ; Su Jin KIM ; Eun Jae CHUNG ; June Young CHOI ; Chang Hwan RYU ; You Jin LEE ; Jeong Hun HAH ; Yuh Seog JUNG ; Junsun RYU ; Yunji HWANG ; Sue K PARK ; Ho Kyung SUNG ; Ka Hee YI ; Do Joon PARK ; Young Joo PARK
Endocrinology and Metabolism 2018;33(3):427-427
No abstract available.
6.Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions.
Si Hyung LEE ; Jee Eun KIM ; Hong Sun JANG ; Kyu Hyun PARK ; Byung Ho OH ; Sang Joon SHIN ; Kee Yang CHUNG ; Mi Ryung ROH ; Sun Young RHA
Cancer Research and Treatment 2018;50(4):1378-1387
PURPOSE: Melanoma is a highly heterogeneous neoplasm, composed of subpopulations of tumor cells with distinct molecular and biological phenotypes and genotypes. In this study, to determine the genetic heterogeneity between primary and metastatic melanoma in Korean melanoma patients, we evaluated several well-known genetic alterations of melanoma. In addition, to elucidate the clinical relevance of each genetic alteration and heterogeneity between primary and metastatic lesions, clinical features and patient outcome were collected. MATERIALS AND METHODS: In addition to clinical data, BRAF, NRAS, GNAQ/11 mutation and KIT amplification data was acquired from an archived primary Korean melanoma cohort (KMC) of 188 patients. Among these patients, 43 patients were included for investigation of tumor heterogeneity between primary melanoma and its corresponding metastatic lesions. RESULTS: Overall incidence of genetic aberrations of the primary melanomas in KMC was 17.6% of BRAF V600, 12.6% of NRAS mutation, and 28.6% of KIT amplification. GNAQ/11 mutation was seen in 66.6% of the uveal melanoma patients. Patients with BRAF mutation were associated with advanced stage and correlated to poor prognosis (p < 0.01). Among 43 patients, 55.8% showed heterogeneity between primary and metastatic lesion. The frequency of BRAF mutation and KIT amplification significantly increased in the metastatic lesions compared to primary melanomas. GNAQ/11 mutation showed 100% homogeneity in uveal melanoma patients. CONCLUSION: Our data demonstrated heterogeneity between primary melanomas and corresponding metastatic lesions for BRAF, NRAS mutation and KIT amplification. However, GNAQ/11 mutation was genetically homogeneous between primary and metastatic melanoma lesions in uveal melanoma.
Cohort Studies
;
Genetic Heterogeneity
;
Genotype
;
Humans
;
Incidence
;
Melanoma*
;
Phenotype
;
Population Characteristics*
;
Prognosis
7.Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro).
Jae Hoon MOON ; Ji hoon KIM ; Eun Kyung LEE ; Kyu Eun LEE ; Sung Hye KONG ; Yeo Koon KIM ; Woo jin JUNG ; Chang Yoon LEE ; Roh Eul YOO ; Yul HWANGBO ; Young Shin SONG ; Min Joo KIM ; Sun Wook CHO ; Su jin KIM ; Eun Jae JUNG ; June Young CHOI ; Chang Hwan RYU ; You Jin LEE ; Jeong Hun HAH ; Yuh Seog JUNG ; Junsun RYU ; Yunji HWANG ; Sue K PARK ; Ho Kyung SUNG ; Ka Hee YI ; Do Joon PARK ; Young Joo PARK
Endocrinology and Metabolism 2018;33(2):278-286
BACKGROUND: The ongoing Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro) aims to observe the natural course of papillary thyroid microcarcinoma (PTMC), develop a protocol for active surveillance (AS), and compare the long-term prognosis, quality of life, and medical costs between the AS and immediate surgery groups. METHODS: This multicenter prospective cohort study of PTMC started in June 2016. The inclusion criteria were suspicious of malignancy or malignancy based on fine needle aspiration or core needle biopsy, age of ≥18 years, and a maximum diameter of ≤1 cm. If there was no major organ involvement, no lymph node/distant metastasis, and no variants with poor prognosis, the patients were explained of the pros and cons of immediate surgery and AS before selecting AS or immediate surgery. Follow-up visits (physical examination, ultrasonography, thyroid function, and questionnaires) are scheduled every 6 months during the first 2 years, and then every 1 year thereafter. Progression was defined as a maximum diameter increase of ≥3, ≥2 mm in two dimensions, suspected organ involvement, or lymph node/distant metastasis. RESULTS: Among 439 enrolled patients, 290 patients (66.1%) chose AS and 149 patients (33.9%) chose immediate surgery. The median follow-up was 6.7 months (range, 0.2 to 11.9). The immediate surgery group had a larger maximum tumor diameter, compared to the AS group (7.1±1.9 mm vs. 6.6±2.0 mm, respectively; P=0.014). CONCLUSION: The results will be useful for developing an appropriate PTMC treatment policy based on its natural course and risk factors for progression.
Biopsy, Fine-Needle
;
Biopsy, Large-Core Needle
;
Cohort Studies*
;
Follow-Up Studies
;
Humans
;
Neoplasm Metastasis
;
Prognosis
;
Prospective Studies*
;
Quality of Life
;
Risk Factors
;
Thyroid Gland*
;
Thyroid Neoplasms
;
Ultrasonography
8.p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer.
Se Hyun KIM ; Kyu Hyun PARK ; Sang Joon SHIN ; Kang Young LEE ; Tae Il KIM ; Nam Kyu KIM ; Sun Young RHA ; Jae Kyung ROH ; Joong Bae AHN
Cancer Research and Treatment 2016;48(1):208-215
PURPOSE: Hypermethylation of the CpG island of p16(INK4a) occurs in a significant proportion of colorectal cancer (CRC). We aimed to investigate its predictive role in CRC patients treated with 5-fluorouracil, leucovorin, irinotecan (FOLFIRI), and cetuximab. MATERIALS AND METHODS: Pyrosequencing was used to identify KRAS mutation and hypermethylation of 6 CpG island loci (p16, p14, MINT1, MINT2, MINT31, and hMLH1) in DNA extracted from formalin-fixed paraffin-embedded specimens. Logistic regression and Cox regression were performed for analysis of the relation between methylation status of CpG island methylator phenotype (CIMP) markers including p16 and clinical outcome. RESULTS: Hypermethylation of the p16 gene was detected in 14 of 49 patients (28.6%) and showed significant association with KRAS mutation (Fisher exact, p=0.01) and CIMP positivity (Fisher exact, p=0.002). Patients with p16-unmethylated tumors had significantly longer time to progression (TTP; median, 9.0 months vs. 3.5 months; log-rank, p=0.001) and overall survival (median, 44.9 months vs. 16.4 months; log-rank, p=0.008) than those with p16-methylated tumors. Patients with both KRAS and p16 aberrancy (n=6) had markedly shortened TTP (median, 2.8 months) compared to those with either KRAS or p16 aberrancy (n=11; median, 8.6 months; p=0.021) or those with neither (n=32; median, 9.0 months; p < 0.0001). In multivariate analysis, KRAS mutation and p16 methylation showed independent association with shorter TTP (KRAS mutation: hazard ratio [HR], 3.21; p=0.017; p16 methylation: HR, 2.97; p=0.027). CONCLUSION: Hypermethylation of p16 was predictive of clinical outcome in metastatic CRC patients treated with cetuximab and FOLFIRI, irrespective of KRAS mutation.
Colorectal Neoplasms*
;
CpG Islands
;
Cyclin-Dependent Kinase Inhibitor p16
;
DNA
;
Drug Therapy*
;
Fluorouracil
;
Genes, p16
;
Humans
;
Leucovorin
;
Logistic Models
;
Methylation
;
Multivariate Analysis
;
Phenotype
9.Novel Methods for Clinical Risk Stratification in Patients with Colorectal Liver Metastases.
Ki Yeol KIM ; Nam Kyu KIM ; In Ho CHA ; Joong Bae AHN ; Jin Sub CHOI ; Gi Hong CHOI ; Joon Suk LIM ; Kang Young LEE ; Seung Hyuk BAIK ; Byung Soh MIN ; Hyuk HUR ; Jae Kyung ROH ; Sang Joon SHIN
Cancer Research and Treatment 2015;47(2):242-250
PURPOSE: Colorectal cancer patients with liver-confined metastases are classified as stage IV, but their prognoses can differ from metastases at other sites. In this study, we suggest a novel method for risk stratification using clinically effective factors. MATERIALS AND METHODS: Data on 566 consecutive patients with colorectal liver metastasis (CLM) between 1989 and 2010 were analyzed. This analysis was based on principal component analysis (PCA). RESULTS: The survival rate was affected by carcinoembryonic antigen (CEA) level (p < 0.001; risk ratio, 1.90), distribution of liver metastasis (p=0.014; risk ratio, 1.46), and disease-free interval (DFI; p < 0.001; risk ratio, 1.98). When patients were divided into three groups according to PCA score using significantly affected factors, they showed significantly different survival patterns (p < 0.001). CONCLUSION: The PCA scoring system based on CEA level, distribution of liver metastasis, and DFI may be useful for preoperatively determining prognoses in order to assist in clinical decisionmaking and designing future clinical trials for CLM treatment.
Carcinoembryonic Antigen
;
Colorectal Neoplasms
;
Humans
;
Liver*
;
Neoplasm Metastasis*
;
Odds Ratio
;
Passive Cutaneous Anaphylaxis
;
Principal Component Analysis
;
Prognosis
;
Survival Rate
10.Foreign Body Reaction to Injectable Hyaluronic Acid: Late Granuloma Formation.
Ji Hoon KIM ; Joon Seok CHOI ; Jeong Hwan YUN ; Hong Kyu KANG ; Jin Ok BAEK ; Joo Young ROH ; Jong Rok LEE
Annals of Dermatology 2015;27(2):224-225
No abstract available.
Foreign-Body Reaction*
;
Granuloma*
;
Hyaluronic Acid*

Result Analysis
Print
Save
E-mail